Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The postantibiotic effect.

J M Spivey1

  • 1Department of Family Medicine, School of Medicine, East Carolina University, Greenville, NC.

Clinical Pharmacy
|October 1, 1992
PubMed
Summary
This summary is machine-generated.

The post-antibiotic effect (PAE) is influenced by specific drug-bug combinations and conditions. Understanding PAE aids in optimizing antimicrobial dosing for better outcomes and reduced toxicity.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lipid and lipoprotein responses to oral combined hormone replacement therapy in normolipemic obese women with controlled type 2 diabetes mellitus.

Journal of clinical pharmacology·2001
Same author

Assessment of the enzymuria resulting from gentamicin alone and combinations of gentamicin with various beta-lactam antibiotics.

The Annals of pharmacotherapy·1997
Same author

Failure of prostatitis treatment secondary to probable ciprofloxacin-sucralfate drug interaction.

Pharmacotherapy·1996
Same author

Dose-ranging pharmacokinetic study of ciprofloxacin after 200-, 300-, and 400-mg intravenous doses.

The Annals of pharmacotherapy·1992
Same author

Mathematic modeling of drug disposition and postdialysis rebound in patients requiring hemodialysis.

Pharmacotherapy·1992
Same author

Theophylline toxicity secondary to ciprofloxacin administration.

Annals of emergency medicine·1991
Same journal

Criteria for use of epoetin alfa in adult cancer and orthopedic-surgery patients.

Clinical pharmacy·1993
Same journal

Accuracy of unbound-quinidine concentration determination after ultrafiltration.

Clinical pharmacy·1993
Same journal

Modified Michaelis-Menten equation for estimating unbound-phenytoin concentrations.

Clinical pharmacy·1993
Same journal

Predicting vancomycin pharmacokinetics by using aminoglycoside pharmacokinetics.

Clinical pharmacy·1993
Same journal

Efficacy of nutritional supplements used by athletes.

Clinical pharmacy·1993
Same journal

Low-molecular-weight heparins for the treatment of deep-vein thrombosis.

Clinical pharmacy·1993
See all related articles

Area of Science:

  • Pharmacology
  • Microbiology
  • Infectious Diseases

Background:

  • The post-antibiotic effect (PAE) is a crucial pharmacokinetic/pharmacodynamic parameter.
  • PAE describes the period of growth inhibition after antibiotic exposure.
  • Understanding PAE is vital for optimizing antimicrobial therapy.

Purpose of the Study:

  • To describe factors influencing the post-antibiotic effect (PAE).
  • To discuss the clinical significance of PAE in antimicrobial therapy.
  • To explore mechanisms and implications of PAE.

Main Methods:

  • Review of factors affecting PAE, including microorganism-antimicrobial combinations, concentrations, and exposure duration.
  • Comparison of PAE across different antibiotic classes and bacterial types (gram-positive vs. gram-negative).

Related Experiment Videos

  • Analysis of in vitro versus in vivo PAE and clinical relevance.

    • Main Results:

    • Microorganism-antimicrobial combination is the primary determinant of PAE.
    • Beta-lactams show minimal PAE against gram-negative bacilli, unlike aminoglycosides and fluoroquinolones.
    • In vivo PAEs are generally longer than in vitro PAEs, supporting clinical utility.

    Conclusions:

    • PAE is influenced by drug, bug, and experimental conditions.
    • Extended dosing intervals for agents with significant PAE may offer clinical benefits.
    • Further research is needed to fully leverage PAE for optimizing antimicrobial dosing, efficacy, and cost-effectiveness.